Factors to consider in the choice of intrathecal drug in the treatment of neuropathic pain

Medication selection for neuropathic pain follows a path of evidence, with respect to appreciating the patient’s entry into the pain care algorithm. As we decide how to approach neuropathic pain, the considerations for intrathecal therapy medication selection are bound by catheter location, region of pain, and patient selection, to name a few. Future research and the 2016 polyanalgesic consensus conference may further provide patient care through a mindful eye on the improvement of patient safety and a reduction of the societal needs of opioids.

[1]  T. Deer,et al.  Intrathecal Therapy: The Burden of Being Positioned as a Salvage Therapy. , 2015, Pain medicine.

[2]  T. Deer,et al.  Intrathecal Pharmacology Update: Novel Dosing Strategy for Intrathecal Monotherapy Ziconotide on Efficacy and Sustainability , 2015, Neuromodulation : journal of the International Neuromodulation Society.

[3]  T. Deer,et al.  Advanced waveforms and frequency with spinal cord stimulation: burst and high-frequency energy delivery , 2015, Expert review of medical devices.

[4]  D. Bouhassira,et al.  Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? , 2015, Pain.

[5]  T. Deer,et al.  One‐Year Outcomes of Spinal Cord Stimulation of the Dorsal Root Ganglion in the Treatment of Chronic Neuropathic Pain , 2015, Neuromodulation : journal of the International Neuromodulation Society.

[6]  D. Caraway,et al.  A Definition of Refractory Pain to Help Determine Suitability for Device Implantation , 2014, Neuromodulation : journal of the International Neuromodulation Society.

[7]  R. Coffey,et al.  Clinical Accuracy and Safety Using the SynchroMed II Intrathecal Drug Infusion Pump , 2014, Regional Anesthesia & Pain Medicine.

[8]  M. Saulino,et al.  Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2012, Neuromodulation : journal of the International Neuromodulation Society.

[9]  J. Merrill,et al.  Opioids in the management of HIV-related pain. , 2012, Pain physician.

[10]  T. Deer.  A critical time for practice change in the pain treatment continuum: we need to reconsider the role of pumps in the patient care algorithm. , 2010, Pain medicine.

[11]  T. Deer,et al.  Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra® Programmable Pump , 2010, Neuromodulation : journal of the International Neuromodulation Society.

[12]  R. Coffey,et al.  Mortality Associated with Implantation and Management of Intrathecal Opioid Drug Infusion Systems to Treat Noncancer Pain , 2009, Anesthesiology.

[13]  C. Bernards.  Cerebrospinal Fluid and Spinal Cord Distribution of Baclofen and Bupivacaine during Slow Intrathecal Infusion in Pigs , 2006, Anesthesiology.

[14]  L. Webster,et al.  A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. , 2006, Journal of pain and symptom management.

[15]  U Klose,et al.  The Influence of Pulse and Respiration on Spinal Cerebrospinal Fluid Pulsation , 2004, Investigative radiology.

[16]  Krishna Kumar,et al.  Epidural spinal cord stimulation for treatment of chronic pain--some predictors of success. A 15-year experience. , 1998, Surgical neurology.